| | |
All participants
|
C-reactive protein (mg/L)
|
|---|
| | | |
≤1
|
1.1-3
|
3.1-10
|
>10
|
|---|
| | |
n = 14,228
|
n = 5,460
|
n = 5,249
|
n = 2,927
|
n = 592
|
|---|
|
Age
| |
58.0 (9.0)
|
55.7 (8.8)
|
59.0 (8.8)
|
60.1 (8.8)
|
60.7 (8.6)
|
|
Haemoglobin A1c (%)**
|
5.3 (0.7)
|
5.1 (0.6)
|
5.3 (0.6)
|
5.4 (0.7)
|
5.6 (0.9)
|
|
Body mass index (Kg/m2)
|
26.1 (3.7)
|
24.7 (3.0)
|
26.5 (3.4)
|
27.8 (4.2)
|
27.5 (4.8)
|
|
Waist Circumference (cm)
|
87.3 (12.1)
|
83.6 (11.2)
|
88.5 (11.6)
|
91.5 (12.2)
|
91.5 (13.0)
|
|
Alcohol (units/week)
| |
7.1 (9.1)
|
7.2 (8.7)
|
7.2 (9.5)
|
6.7 (9.5)
|
6.5 (8.6)
|
|
Sex (% male)
| |
6,211 (43.7 %)
|
2,412 (44.2 %)
|
2,361 (45.0 %)
|
1,177 (40.2 %)
|
261 (44.1 %)
|
|
Smoking
|
Current
|
1,488 (10.5 %)
|
445 (8.2 %)
|
530 (10.2 %)
|
413 (14.3 %)
|
100 (17.0 %)
|
| |
Former
|
5,825 (41.3 %)
|
2,060 (37.9 %)
|
2,262 (43.4 %)
|
1,249 (43.1 %)
|
254 (43.3 %)
|
| |
Never
|
6,809 (48.2 %)
|
2,926 (53.9 %)
|
2,415 (46.4 %)
|
1,235 (42.6 %)
|
233 (39.7 %)
|
|
Physical activity
|
Inactive
|
3,958 (27.8 %)
|
1,196 (21.9 %)
|
1,523 (29.0 %)
|
1,016 (34.7 %)
|
223 (37.7 %)
|
| |
Moderately inactive
|
4,104 (28.8 %)
|
1,582 (29.0 %)
|
1,525 (29.1 %)
|
825 (28.2 %)
|
172 (29.1 %)
|
| |
Moderately active
|
3,370 (23.7 %)
|
1,433 (26.3 %)
|
1,214 (23.1 %)
|
608 (20.8 %)
|
115 (19.4 %)
|
| |
Active
|
2,796 (19.7 %)
|
1,249 (22.9 %)
|
987 (18.8 %)
|
478 (16.3 %)
|
82 (13.9 %)
|
|
Prevalent disease
|
Cancer
|
733 (5.2 %)
|
239 (4.4 %)
|
287 (5.5 %)
|
171 (5.8 %)
|
36 (6.1 %)
|
| |
Myocardial Infarction
|
392 (2.8 %)
|
87 (1.6 %)
|
162 (3.1 %)
|
107 (3.7 %)
|
36 (6.1 %)
|
| |
Stroke
|
166 (1.2 %)
|
41 (0.8 %)
|
65 (1.2 %)
|
48 (1.6 %)
|
12 (2.0 %)
|
|
Corticosteroid medication use
|
408 (2.9 %)
|
103 (1.9 %)
|
147 (2.8 %)
|
121 (4.1 %)
|
37 (6.3 %)
|
|
Postmenopause
| |
6,129 (76.5 %)
|
2,024 (66.4 %)
|
2,324 (80.5 %)
|
1,505 (86.1 %)
|
276 (83.4 %)
|
|
Hormone replacement therapy (% current use)
|
1,751 (21.9 %)
|
435 (14.3 %)
|
658 (22.8 %)
|
542 (31.0 %)
|
116 (35.1 %)
|
- *Values are mean (standard deviation) or number (%)
- **Baseline characteristics are presented for all participants who had C-reactive protein data at baseline health examination and were included in either the cross-sectional or longitudinal analyses conducted in this study. The mean (SD) of Haemoglobin A1c presented in this table is based on a total of 7,485 participants who had Haemoglobin A1c measurement at baseline. All other baseline characteristics are presented for a total of 14,228 participants who had Haemoglobin A1c measured at a minimum of one health examination
